VCID: 14398069
Profile

Corporate information

Investment activity status
Active investor

Funds managed

Fund Type Vintage
Inning One Ventures LP

Selected investments

Country Date Notes
Ajax Therapeutics Inc
Blood cancer biotech. 		United States 13 May 2024 Series C
Follow-on investment. Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.